We compared the test characteristics of the shock index (SI) and the simplified pulmonary embolism severity index (sPESI) for predicting 30-day outcomes in a cohort of 1,206 patients with objectively confirmed pulmonary embolism (PE). The primary outcome of the study was all-cause mortality. The secondary outcome was nonfatal symptomatic recurrent venous thromboembolism (VTE) or nonfatal major bleeding. Overall, 119 (9.9%) out of 1,206 patients died (95% CI 8.2-11.5%) during the first month of follow-up. The sPESI classified fewer patients as low-risk (369 (31%) out of 1,206 patients, 95% CI 28-33%) compared to the SI (1,024 (85%) out of 1,206 patients, 95% CI 83-87%) (p<0.001). Low-risk patients based on the sPESI had a lower 30-day mortal...
Background. The Pulmonary Embolism Severity Index (PESI) score can risk-stratify patients with PE bu...
Abstract Background Prognostic assessment is important for the management of patients with acute pul...
Background Clinical parameters, biomarkers and imaging-based risk stratification are widely accepted...
The Pulmonary Embolism Severity Index (PESI) is a validated clinical prognostic model for patients w...
The Pulmonary Embolism Severity Index (PESI) is a validated clinical prognostic model for patients w...
Although the Pulmonary Embolism Severity Index (PESI) accurately identifies 35% of patients with acu...
International audienceINTRODUCTION: The pulmonary embolism severity index (PESI) and the recently de...
INTRODUCTION The Pulmonary Embolism Severity Index (PESI) is a validated prognostic score to esti...
BACKGROUND: The Pulmonary Embolism Severity Index (PESI) estimates the risk of 30-day mortality in p...
Pulmonary embolism severity index (PESI) as an example of clinical model which was designed in 2005,...
Background: Patients with suspected pulmonary embolism (PE) should be evaluated for the clinical pro...
Practice guidelines recommend outpatient care for selected patients with non-massive pulmonary embol...
International audiencePractice guidelines recommend outpatient care for selected patients with non-m...
BackgroundThe Pulmonary Embolism Severity Index (PESI) and the simplified PESI (sPESI) are validated...
Rationale: Patients with acute symptomatic pulmonary embolism (PE) deemed to be at low risk for earl...
Background. The Pulmonary Embolism Severity Index (PESI) score can risk-stratify patients with PE bu...
Abstract Background Prognostic assessment is important for the management of patients with acute pul...
Background Clinical parameters, biomarkers and imaging-based risk stratification are widely accepted...
The Pulmonary Embolism Severity Index (PESI) is a validated clinical prognostic model for patients w...
The Pulmonary Embolism Severity Index (PESI) is a validated clinical prognostic model for patients w...
Although the Pulmonary Embolism Severity Index (PESI) accurately identifies 35% of patients with acu...
International audienceINTRODUCTION: The pulmonary embolism severity index (PESI) and the recently de...
INTRODUCTION The Pulmonary Embolism Severity Index (PESI) is a validated prognostic score to esti...
BACKGROUND: The Pulmonary Embolism Severity Index (PESI) estimates the risk of 30-day mortality in p...
Pulmonary embolism severity index (PESI) as an example of clinical model which was designed in 2005,...
Background: Patients with suspected pulmonary embolism (PE) should be evaluated for the clinical pro...
Practice guidelines recommend outpatient care for selected patients with non-massive pulmonary embol...
International audiencePractice guidelines recommend outpatient care for selected patients with non-m...
BackgroundThe Pulmonary Embolism Severity Index (PESI) and the simplified PESI (sPESI) are validated...
Rationale: Patients with acute symptomatic pulmonary embolism (PE) deemed to be at low risk for earl...
Background. The Pulmonary Embolism Severity Index (PESI) score can risk-stratify patients with PE bu...
Abstract Background Prognostic assessment is important for the management of patients with acute pul...
Background Clinical parameters, biomarkers and imaging-based risk stratification are widely accepted...